Roche strikes obesity drug licensing deal worth up to $1.16 bln with Chinese Rona Therapeutics - Reuters

Reuters

Roche strikes obesity drug licensing deal worth up to $1.16 bln with Chinese Rona Therapeutics Reuters

Roche strikes obesity drug licensing deal worth up to $1.16 bln with Chinese Rona Therapeutics Reuters

Ver fuente original → ← Volver a noticias